表紙
市場調査レポート

眼内黒色腫:世界の治験動向

Ocular Melanoma Global Clinical Trials Review, H2, 2016

発行 GlobalData 商品コード 299720
出版日 ページ情報 英文 138 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.12円で換算しております。
Back to Top
眼内黒色腫:世界の治験動向 Ocular Melanoma Global Clinical Trials Review, H2, 2016
出版日: 2016年07月29日 ページ情報: 英文 138 Pages
概要

当レポートでは、眼内黒色腫治療薬に関する治験の最新動向について分析しており、G7 (主要7カ国) における治験件数、被験者数、有望なスポンサー、治験に携わっている主な企業や機関、有望な薬剤の情報をまとめています。

当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要5ヶ国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要国における治験件数

G7諸国での治験件数:癌治療薬の治験における眼内黒色腫の割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

眼内黒色腫治療薬の治験に携わっている主要企業

有望な薬剤

治験プロファイルの概要

付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC3624CTIDB

GlobalData's clinical trial report, "Ocular Melanoma Global Clinical Trials Review, H2, 2016" provides an overview of Ocular Melanoma clinical trials scenario. This report provides top line data relating to the clinical trials on Ocular Melanoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 3
  • Report Guidance 4
  • Clinical Trials by Region 5
  • Clinical Trials and Average Enrollment by Country 6
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 8
  • Top Five Countries Contributing to Clinical Trials in Europe 9
  • Top Countries Contributing to Clinical Trials in North America 10
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 11
  • Clinical Trials by G7 Countries: Proportion of Ocular Melanoma to Oncology Clinical Trials 12
  • Clinical Trials by Phase in G7 Countries 13
  • Clinical Trials in G7 Countries by Trial Status 14
  • Clinical Trials by Phase 15
  • In Progress Trials by Phase 16
  • Clinical Trials by Trial Status 17
  • Clinical Trials by End Point Status 18
  • Subjects Recruited Over a Period of Time 19
  • Clinical Trials by Sponsor Type 20
  • Prominent Sponsors 21
  • Top Companies Participating in Ocular Melanoma Therapeutics Clinical Trials 22
  • Prominent Drugs 24
  • Clinical Trial Profile Snapshots 25

Appendix 135

  • Abbreviations 135
  • Definitions 135
  • Research Methodology 136
  • Secondary Research 136
  • About GlobalData 137
  • Contact Us 137
  • Disclaimer 137
  • Source 138

List of Tables

List of Tables

  • Ocular Melanoma Therapeutics, Global, Clinical Trials by Region, 2016* 5
  • Ocular Melanoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6
  • Ocular Melanoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7
  • Ocular Melanoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 8
  • Ocular Melanoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 9
  • Ocular Melanoma Therapeutics Clinical Trials, North America, Top Countries, 2016* 10
  • Ocular Melanoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 11
  • Proportion of Ocular Melanoma to Oncology Clinical Trials, G7 Countries (%), 2016* 12
  • Ocular Melanoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 13
  • Ocular Melanoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 14
  • Ocular Melanoma Therapeutics, Global, Clinical Trials by Phase, 2016* 15
  • Ocular Melanoma Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 16
  • Ocular Melanoma Therapeutics, Global, Clinical Trials by Trial Status, 2016* 17
  • Ocular Melanoma Therapeutics Clinical Trials, Global, by End Point Status, 2016* 18
  • Ocular Melanoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 19
  • Ocular Melanoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 20
  • Ocular Melanoma Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 21
  • Ocular Melanoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 23
  • Ocular Melanoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 24

List of Figures

List of Figures

  • Ocular Melanoma Therapeutics, Global, Clinical Trials by Region (%), 2016* 5
  • Ocular Melanoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6
  • Ocular Melanoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7
  • Ocular Melanoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 8
  • Ocular Melanoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 9
  • Ocular Melanoma Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 10
  • Proportion of Ocular Melanoma to Oncology Clinical Trials, G7 Countries (%), 2016* 12
  • Ocular Melanoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 13
  • Ocular Melanoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 14
  • Ocular Melanoma Therapeutics, Global, Clinical Trials by Phase (%), 2016* 15
  • Ocular Melanoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 16
  • Ocular Melanoma Therapeutics, Global, Clinical Trials by Trial Status, 2016* 17
  • Ocular Melanoma Therapeutics Clinical Trials, Global, by End Point Status, 2016* 18
  • Ocular Melanoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 19
  • Ocular Melanoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 20
  • Ocular Melanoma Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 21
  • Ocular Melanoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 22
  • Ocular Melanoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 24
  • GlobalData Methodology 136
Back to Top